Kathleen Laporte - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of Kathleen Laporte is at least $339K dollars as of October 2, 2024. Kathleen Laporte is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $174K. Kathleen Laporte is the Director of CERO THERAPEUTICS HOLDINGS, INC. and owns shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO) stock worth about $97.2K. Kathleen Laporte is the Director of Precipio, Inc. and owns shares of Precipio, Inc. (PRPO) stock worth about $67.5K.
All Insider Reports
All Insider Reports

Ownership of Kathleen Laporte

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QTTB Q32 Bio Inc. Director $174K Mar 25, 2024
CERO, CEROW CERO THERAPEUTICS HOLDINGS, INC. Director $97.2K Sep 25, 2024
PRPO Precipio, Inc. Director $67.5K Aug 31, 2024
ETNB 89bio, Inc. Director Feb 1, 2024
BOLT Bolt Biotherapeutics, Inc. Director Jun 12, 2024

Insider Transactions Reported by Kathleen Laporte:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.